Your session is about to expire
← Back to Search
Palliative Care for Cancer
N/A
Waitlist Available
Led By Amber Barnato, MD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will help researchers learn if patients and their caregivers are able and willing to come to Dartmouth College for two visits while receiving cancer care at Dartmouth-Hitchcock Medical Center.
Who is the study for?
This trial is for adults over 18 who've been diagnosed with metastatic lung or gastrointestinal cancer in the last 8 weeks. Their care partners can also join if they consent. Participants must understand English and be able to make informed decisions about joining.Check my eligibility
What is being tested?
The study is testing the feasibility of patients with cancer and their care partners attending two study visits at Dartmouth College while receiving treatment nearby. It aims to assess willingness and ability to participate in such a setting.See study design
What are the potential side effects?
Since this trial involves palliative care rather than drug treatments, there are no typical medication side effects; however, participants may experience emotional or psychological discomfort when discussing sensitive topics related to their illness.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Operationalization as measured by the creation of a manual of operating procedures and web-based data collection forms
Secondary outcome measures
Acceptability as measured by response to questions of level of burden.
Acceptability as measured by willingness to recommend study participation to others.
Feasibility as measured by enrollment number
+6 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Arm 1Experimental Treatment1 Intervention
Patients and care partners receive specialty primary care and participate in pre- and post- functional MRI scans to measure the effects of the specialty palliative care intervention.
Find a Location
Who is running the clinical trial?
Dartmouth-Hitchcock Medical CenterLead Sponsor
524 Previous Clinical Trials
2,543,334 Total Patients Enrolled
Dartmouth CollegeOTHER
79 Previous Clinical Trials
1,415,567 Total Patients Enrolled
Amber Barnato, MDPrincipal InvestigatorDartmouth-Hitchcock Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are afraid of small or enclosed spaces.Your doctor expects you to live less than 8 weeks.
Research Study Groups:
This trial has the following groups:- Group 1: Arm 1
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this clinical trial still recruiting participants?
"As of the last update on November 1st 2022, this clinical trial is not presently seeking participants. Nonetheless, there are 672 other medical studies that remain open and actively recruiting patients."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger